Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
See all recalls from Biohaven Pharmaceuticals Inc., of New Haven, Conn. →Recalled Product
Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack
Hazard / Issue
None reported
Issued by
CPSC
Distribution: Nationwide (United States)
Sold at: Pharmacies nationwide as a prescribed medicine from December 2021 through March 2023. The prices of the product varied based on health insurance terms and other factors.
What to do: Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.
View on CPSC.gov →
✅ What Should You Do?
- 1Stop using the product immediately.
- 2Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.
- 3Keep the product (do not throw it away) until you have received your remedy or refund confirmation.
- 4Report injuries to SaferProducts.gov.
Looking for a safe alternative?
Search Amazon for Nurtec® ODT (rimegepant) orally →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime